Throughout my academic career, I have always had a natural curiousity about the life sciences. I completed my honours bachelors of science degree at the University of Toronto majoring in biology and chemistry. My interests during my undergraduate led me towards my doctoral work in medicinal chemistry, where I explored the design and synthesis of novel drug modalities as potential cancer therapeutics. Throughout my PhD, I was very fortunate to have had many opportunities to communicate my research at national conferences and in peer-reviewed publications. I loved using my visual talents to develop figures and movies in order to make my work accessible to larger audiences. In addition, I enjoyed making creative, visual analogies of my research and was thrilled that my designs were selected as front covers for several publications. Supplementing my interest in visualizing science is a love of teaching that grew from tutoring and lecturing experiences throughout my undergraduate and doctoral degrees. Eventually, I found myself swayed away from the bench top and towards the BMC program. The BMC program sits at the interface of several disciplines, with education, science and art being a few of these disciplines that mirror my own passions. I look forward to learning and growing with my fellow BMC classmates over the next couple years while developing the skills I need to optimally communicate science and health topics to future generations.
Please feel free to sort through my CV below.
Cheers,
Haftchenary, S.; Ball, D.P.; Aubry, I.; Landry, M.; Shahani, V.M.; Fletcher, S.; Page, B.D.G; Jouk, A.O.; Tremblay, M.L.; Gunning, P.T. (2013) "Identification of a Potent Salicylic Acid-based Inhibitor of Tyrosine Phosphatase PTP1B." MedChemComm.
Shahani, V.M.; Ball, D.P.; Ramos, A.V.; Li, Z.; Spagnulo, P.A.; Haftchenary, S.; Trudel, S.; Schimmer, A.D.; Gunning P.T. (2013) "A 2,6,9- hetero-trisubstituted purine inhibitor exhibits potent biological effects against multiple myeloma cells". Bioorganic & Medicinal Chemistry.
Lukkarila, J.L.; da Silva, S.R.; Ali, M.; Shahani, V.M.; Xu, W.G.; Berman, J.; Roughton, A.; Dhe-Paganon, S.; Schimmer, A.D.; Gunning, P.T. (2011) "Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity."ACS Med. Chem. Lett. (2), 577–582.
Shahani, V.M.; Fletcher, S.; Yue, P.; Luu, D.; Sharmeen, S.; Schimmer, A.S.; Turkson, J.; Gunning, P. T. (2011) "Design, synthesis and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein." Bioorg. Med. Chem. (19), 1823-1838.
Shahani, V.M.; Yue, P.; Haftchenary, S.; Zhao, W.; Lukkarila, J.; Zhang, X.; Ball, D.; Nona, C.; Gunning, P. T.; Turkson, J. (2011) "Identification of purine-scaffold small-molecule inhibitors of Stat3 activation by quantitative structure activity relationship studies." ACS Med. Chem. Lett., 2011, 2 (1), pp 79–84.
Fletcher, S.; Shahani, V.M.; and Gunning, P.T. (2010) "Concise access to N9-mono-, N2-mono- and N2,N9-di-substituted guanines via efficient Mitsunobu reactions." Tetrahedron. (66), 4621-4632.
Fletcher, S.; Drewry, J.; Shahani, V.M.; Page, B.D.G; Gunning, P.T.; (2009) "Molecular Disruption of Oncogenic Signal Transducer and Activator of Transcription 3 (STAT3) Protein." Biochem. Cell Biol. (87), 825-833.
Fletcher, S.; Singh, J.; Zhange, X.; Yue, P,; Page, B.D.G.; Sharmeen, S.; Shahani, V.M.; Schimmer, A.D.; Turkson, J.; Gunning, P.T. (2009) "Disruption of Transcriptionally Active Stat3 Dimers with Non-phosphorylated, Salicylic Acid-Based Small Molecules: Potent in vitro and Tumor Cell Activities." ChemBioChem, (10), 1959-1964.
Fletcher, S.; Shahani, V.M.; Gunning, P.T. (2009) "Facile and efficient access to 2,6,9-tri-substituted purines through sequential N9, N2 Mitsunobu reactions." Tet. Lett. (50), 4258-4261.
Shahani, V.M.; Ball, D.P.; and Gunning, P. T. "Second Generation Purine Inhibitors of Stat3 Show Greater Than 6-fold Increased Activity Over Previous Library" 95th Canadian Chemistry Conference and Exhibition. Calgary, AB, Canada. Oral Presentation. June 2012.
Shahani, V.M.; Ball, D.P.; and Gunning, P. T. "Decorating purine-based STAT3 inhibitors with drug-like functionalities to improve cell permeability and anti-cancer potency" 94th Canadian Chemistry Conference and Exhibition. Montreal, QC, Canada. Oral Presentation. June 2011.
Shahani, V.M.; Fletcher, S.; and Gunning, P. T. “Utilizing a pharmacophore model for the development of potent small molecule inhibitors of STAT3 function” ACS National Meeting. Boston, MA, USA. Poster Presentation. August 2010.
Haftchenary, C.; Shahani, V.M.; Fletcher, S.; and Gunning, P. T. “Design and Synthesis of 2,6,9-hetero-trisubstituted Purine Inhibitors of the Stat3-SH2 Domain” 93rd Canadian Chemistry Conference and Exhibition. Poster Presentation. May 2010.
Shahani, V.M.; Fletcher, S.; and Gunning, P. T. “A Peptidomimetic STAT3 Inhibitor Sensitizes Human Prostate Cancer Cells to Chemotherapeutic Treatment: A Promising Synergistic Combination Strategy” 93rd Canadian Chemistry Conference and Exhibition. Oral Presentation. May 2010.
Shahani, V.M; Fletcher, S.; and Gunning, P. T. “Strategic Design and Synthesis of Highly Effective Peptidomimetic Inhibitors of STAT3” 92nd Canadian Chemistry Conference and Exhibition. Poster Presentation. May 2009.